ADVFN US – Market Content Editor
-

TEGNA Shares Gain After Nexstar Unveils $6.2 Billion Acquisition Plan
TEGNA Inc. (NYSE:TGNA) stock climbed 2.8% on Tuesday after Nexstar Media Group (NASDAQ:NXST) announced it would acquire the broadcaster in a $6.2 billion all-cash deal. The agreement values TEGNA at $22 per share, a 31% premium over the company’s 30-day average stock price ending August 8, 2025. TEGNA’s board has unanimously approved the transaction, which…
-

Opera Stock Climbs as Q2 Results Top Forecasts, Outlook Raised
Opera Limited (NASDAQ:OPRA) saw its shares gain nearly 3% in pre-market trading on Tuesday after the browser and AI-driven services company reported second-quarter results that came in ahead of Wall Street expectations and lifted its full-year guidance. Adjusted earnings per share came in at $0.26, well above analyst projections of $0.20. Revenue surged 30% year-over-year…
-

Viking Therapeutics Plunges 37% on Obesity Drug Trial Concerns
Shares of Viking Therapeutics (NASDAQ:VKTX) tumbled as much as 37% on Tuesday after the company released data from its Phase 2 VENTURE-Oral Dosing trial for its experimental oral obesity treatment. In contrast, Eli Lilly (NYSE:LLY) stock gained 1.5% as analysts emphasized the strength of its competing therapies. The trial results showed that Viking’s oral formulation…
-

Viking Holdings Tops Expectations with Strong Q2 Performance and 18.5% Revenue Growth
Viking Holdings Ltd (NYSE:VIK) announced second-quarter results on Tuesday that beat Wall Street forecasts, as both earnings and revenue came in ahead of consensus. Adjusted earnings per share were $0.99, topping analyst estimates of $0.79, while quarterly revenue reached $1.88 billion, up 18.5% from the same period a year earlier. Shares of the cruise operator…
-

PTC Therapeutics Shares Drop After FDA Rejects Vatiquinone Application
PTC Therapeutics, Inc. (NASDAQ:PTCT) saw its stock slide 5% after the U.S. Food and Drug Administration (FDA) declined to approve its New Drug Application (NDA) for vatiquinone, a treatment candidate for Friedreich’s ataxia. The decision came in the form of a Complete Response Letter (CRL). In its letter, the FDA said that PTC had not…
-

Premier Surpasses Q4 Earnings and Revenue Estimates, Shares Tick Up
Premier, Inc. (NASDAQ:PINC) reported fourth-quarter results on Tuesday that outperformed analyst expectations. Adjusted earnings per share came in at $0.46, beating estimates by $0.12, while revenue totaled $262.9 million, above the consensus of $247.13 million. Following the announcement, Premier’s shares rose slightly, gaining 0.25% in after-hours trading. The healthcare improvement company saw total net revenue…
-

Home Depot Shares Drop After Q2 Results Fall Short of Expectations
Home Depot (NYSE:HD) reported fiscal Q2 2025 results that fell below analyst forecasts, causing shares to slide 2.5%, even though both revenue and earnings showed year-over-year growth. The home improvement giant posted adjusted earnings per share of $4.68, missing estimates of $4.72. Revenue reached $45.3 billion, slightly below the consensus forecast of $45.44 billion. Still,…
-

Amer Sports Exceeds Q2 Expectations, Raises Forecast Despite Tariff Headwinds
Amer Sports, Inc. (NYSE:AS) reported second-quarter results on Tuesday that surpassed analyst expectations, posting adjusted earnings per share of $0.06, well above the predicted -$0.02. Revenue climbed 23% to $1.24 billion, fueled by strong sales across its premium sports and outdoor brands. Shares slipped 2.29% in pre-market trading following the announcement. Revenue from Technical Apparel…
-

Intel shares surge as SoftBank commits $2 billion to chipmaker
Shares of Intel (NASDAQ:INTC) jumped nearly 6% in premarket trading Tuesday after SoftBank Group Corp. (USOTC:SFTBY) announced plans to invest $2 billion in the U.S. chipmaker. The Japanese conglomerate aims to help Intel develop advanced semiconductor manufacturing facilities in the United States. SoftBank will acquire Intel common stock at $23 per share, slightly below Intel’s…
-

Palo Alto Networks jumps on strong Q4 results and upbeat guidance
Shares of Palo Alto Networks (NASDAQ:PANW) climbed more than 5% in premarket trading Tuesday after the cybersecurity firm posted quarterly results and issued guidance that exceeded Wall Street expectations. The company reported adjusted earnings of 95 cents per share for the fourth quarter ended in July, surpassing analysts’ consensus of 89 cents. Revenue came in…